1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Kahler Disease in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gu, C; Huang, H; Kang, L; Ke, M; Liu, H; Wang, L; Wang, Y; Yang, S; Yang, Y | 1 |
| Denizot, Y; Dupuis, F; Praloran, V; Trimoreau, F; Verger, C | 1 |
| Berg, A; Le Blanc, K; Palmblad, J; Samuelsson, J | 1 |
| Denizot, Y; Desplat, V; Dulery, C; Faucher, JL; Praloran, V | 1 |
| de Nicolas, R; Egido, J; Gonzalez, E; Hernando, P | 1 |
5 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Kahler Disease
| Article | Year |
|---|---|
CAR-T therapy alters synthesis of platelet-activating factor in multiple myeloma patients.
Topics: Humans; Immunotherapy, Adoptive; Lipid Metabolism; Metabolome; Multiple Myeloma; Platelet Activating Factor; Protein Biosynthesis | 2021 |
Platelet-activating factor concentrations in bone marrow of patients with lymphoid and nonlymphoid hematologic malignancies.
Topics: Aged; Bone Marrow; Female; Humans; Leukemia; Lymphoma; Male; Middle Aged; Multiple Myeloma; Platelet Activating Factor; Waldenstrom Macroglobulinemia | 1995 |
Stimulus-specific defect in platelet aggregation in polycythemia vera.
Topics: Adenosine Diphosphate; Aged; Aged, 80 and over; Blood Platelets; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Luminescent Measurements; Middle Aged; Multiple Myeloma; Platelet Activating Factor; Platelet Aggregation; Polycythemia Vera; Tetradecanoylphorbol Acetate | 1994 |
Metabolism and effect of platelet-activating factor on the growth of human myeloma cell lines.
Topics: Cell Division; Humans; Multiple Myeloma; Platelet Activating Factor; Platelet Membrane Glycoproteins; Radioligand Assay; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Tumor Cells, Cultured | 2000 |
IgA immune aggregates stimulate platelet-activating factor and superoxide anion production by human neutrophils. A comparison with IgG aggregates.
Topics: Cytochalasin B; Humans; Immunoglobulin A; Immunoglobulin Fab Fragments; Immunoglobulin G; In Vitro Techniques; Macromolecular Substances; Multiple Myeloma; Neutrophils; Platelet Activating Factor; Reference Values; Superoxides; Tetradecanoylphorbol Acetate | 1991 |